Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
2
×
cancer
detroit blog main
detroit top stories
immunotherapy
2
×
indiana blog main
indiana top stories
life sciences
merck
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
2
×
texas top stories
wisconsin blog main
wisconsin top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
What
advantages
annual
ash
bar
barcelona
bio
brings
cancer
clinical
conference
december's
drug
esmo
european
expect
gamble
kras
major
market
medco’s
medical
meeting
mover
new
oncology
parp
patients
payers
physicians
plan
pricing
prostate
roundup
seagen’s
sets
society
type
ubiome
undone
update
Language
unset
2
×
Current search:
immunotherapy
×
unset
×
" texas blog main "
×
" bristol-myers squibb "
×
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone